Investors

Press Releases

Post Types

Our Story

The idea of OrgHarvest was ‘sprouted’ last year during the ‘hemp rush’ that followed the passage of the 2018 U.S. Farm Bill.  This Bill removed hemp and hemp seeds from the statutory definition of marijuana and the DEA schedule of Controlled Substances. As a result of this declassification, there was a significant surge in hemp production.  The U.S. market was flooded with hemp, some of it offered by inexperienced growers and some of reflecting unstable genetics. In addition, the chaotic environment resulted in a lack of transparency.

The market hemp rush reinforced the OrgHarvest move to hemp from cannabis. The move us the agility to build a robust business within an established, federally regulated market; operating across national and international channels. The global hemp market is project to grow to $26.6 billion USD by 2025, recording a CAGR of 34%. When the U.S. federal laws change, OrgHarvest can leverage the globally established seed-to-consumer infrastructure to include cannabis.

Today, OrgHarvest has a premier genetics bank, exclusive farmer partnerships, propriety patent and rights for flow separation and measurement equipment, the ability to process wet and dry hemp, along with extensive manufacturing and warehouse relationships

Financial Reporting

Company Structure

Listing

OTCMKTS: ORGH

Listing

OTCMKTS: ORGH

Transfer Agent

ClearTrust, LLC
16540 Pointe Village Dr Ste 205
Lutz, FL 33558
1-813-235-4490

Transfer Agent

ClearTrust, LLC
16540 Pointe Village Dr Ste 205
Lutz, FL 33558
1-813-235-4490

Address

OrgHarvest
5950 Berkshire Lane #1460
Dallas, TX 75225
1-214-380-9702
[email protected]

Address

OrgHarvest
5950 Berkshire Lane #1460
Dallas, TX 75225
1-214-380-9702
[email protected]

Board of Directors

Larry Cantrell
Christopher Pittman, Esq.
Dr. John Barnett

Board of Directors

Larry Cantrell
Christopher Pittman, Esq.
Dr. John Barnett

Advisory Board

Dr. Christina Rahm Cook
Gary Allen
Gregg Cordaro

Advisory Board

Dr. Christina Rahm Cook
Gary Allen
Gregg Cordaro

Investor Relations

Bobbie Wasserman
1-214-380-9702 x2
[email protected]

Investor Relations

Bobbie Wasserman
1-214-380-9702 x2
[email protected]

Sign up for our newsletter and investor alerts here: 

Scroll to Top